Effectiveness of t-PA in acute ischemic stroke: Outcome relates to appropriateness

Neurology

Volumn 54, Issue 3, 2000, Pages 679-684

  Buchan, Alastair M ^a,b   Barber, P A ^a   Newcommon, N ^a   Karbalai, H G ^a   Demchuk, A M ^a   Hoyte, K M ^a   Klein, G M ^a   Feasby, T E ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

Acute ischemic stroke; Middle cerebral artery; Tissue type plasminogen activator

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; HEPARIN;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCORING SYSTEM; STROKE; TREATMENT OUTCOME;

EID: 0034620596     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.3.679     Document Type: Article

References (21)

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Steiner T, Bluhmki E, Kaste M, et al. The ECASS 3-hour cohort: secondary analysis of ECASS data by time stratification. Cerebrovasc Disord 1998;8:198-203.
3. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025.
4. Hacke W, Kaste M, Fieschi C, et al. Randomized double blind placebo controlled trial of thrombolytic therapy with intravenous altepase in acute ischemic stroke (ECASSII). Lancet 1998;352:1245-1251.
5. Wardlaw J, Warlow CP, Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischemic stroke. Lancet 1997;350:607-615.
6. Adams HP, Brott TG, Furlan A, et al. Guidelines for thrombolytic therapy for acute ischemic stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. Stroke 1996;27:1711-1718.
7. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice advisory: thrombolytic therapy for acute ischemic stroke - summary statement. Neurology 1996;47:835-839.
8. Norris J, Buchan AM, Cote R, et al. Canadian guidelines for intravenous thrombolytic treatment with acute stroke. Can J Neurol Sci 1988;25:257-259.
9. Cochrane AL. Effectiveness and efficiency: random reflections on health services. London: Nuffield Provincial Hospitals, Trust, 1972.
10. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318:1728-1733.
11. Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998;279:1265-1272.
12. Chiu D, Kriegler D, Villar-Cordova C, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety and efficacy in the first year of clinical practice. Stroke 1998;29:18-22.
13. Tanne D, Bates VE, Verro P, et al. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. Neurology 1999;53:424-427.
14. Multicenter Acute Stroke Trial-Europe (MAST-E) Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med 1996;335:145-150.
15. Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischemic stroke. Lancet 1995;346:1509-1514.
16. Donnan GA, Davis SM, Chambers BR, et al. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study. JAMA 1996;276:961-966.
17. Demchuk AM, Morgenstern LB, Kriegler D, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999;30:34-39.
18. Villar-Cordova C, Morgenstern LB, Barnholtz JS, Frankowski RF, Grotta JC. Neurologists' attitudes regarding rt-PA for acute ischemic stroke. Neurology 1998;50:1491-1494.
19. Sandercock P. Thrombolysis for stroke: opinion 4. Cerebrovasc Disord 1998;8:196-197.
20. Horowitz SH. Thrombolytic therapy in acute stroke: neurologists, get off your hands. Arch Neurol 1998;55:155-157.
21. Von Kummer R, Allen KL, Holle R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997;205:327-333.